[Disseminated Mycobacterium marinum infection].
Bodemer
C
C
Unité de Dermatologie pédiatrique, Hôpital Necker-Enfants Malades, Paris.
Durand
C
C
Blanche
S
S
Teillac
D
D
De Prost
Y
Y
D002675:Child, Preschool; D002991:Clofazimine / Q000627:therapeutic use; D003241:Consanguinity; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006529:Hepatomegaly / Q000209:etiology; D006801:Humans; D007111:Immunity, Cellular; D007592:Joint Diseases / Q000209:etiology; D009164:Mycobacterium Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D012293:Rifampin / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D004977:Ethambutol; D002991:Clofazimine; D012293:Rifampin
Infection disséminée à Mycobacterium marinum.